drugset / Trial / NCT06848595

Mg Sulfate Versus Dexmedetomidine on Cerebral Oxygen Saturation

NCT06848595

Phase 3 Not yet recruiting 90 enrolled Tanta University
RandomizedParallel-groupTriple-blindTreatment

Summary

This study is to evaluate the effects of dexmedetomidine and magnesium sulfate on cerebral oxygen saturation in patients undergoing spine surgeries as adjuvant to general anesthesia guided by cerebral oximetry. The main aims to are Incidence of cerebral desaturation events and duration of cerebral desaturation events.

Timeline

Start
2025-02-23
Primary completion
2027-01-20
Completion
2027-01-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous
Comparator Magnesium Sulfate Other / unclassified 10 mg/kg Intravenous

Indications

No indication recorded.